These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9398340)

  • 21. Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations.
    Ugozzoli LA; Hamby K
    Mol Cell Probes; 2004 Jun; 18(3):161-6. PubMed ID: 15135449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania.
    Frenţescu L; Brownsell E; Hinks J; Malone G; Shaw H; Budişan L; Bulman M; Schwarz M; Pop L; Filip M; Tomescu E; Moşescu S; Popa I; Benga G
    J Cyst Fibros; 2008 Sep; 7(5):423-8. PubMed ID: 18467194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SSCP/heteroduplex analysis.
    Wallace AJ
    Methods Mol Biol; 2002; 187():151-63. PubMed ID: 12013742
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of polymerase chain reaction amplifications through phosphate detection using an enzyme-based microbiosensor in a microfluidic device.
    Shiddiky MJ; Rahman MA; Park JS; Shim YB
    Electrophoresis; 2006 Jul; 27(14):2951-9. PubMed ID: 16645977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of the digit lengths and the anogenital distance in mice.
    Manno FA
    Physiol Behav; 2008 Jan; 93(1-2):364-8. PubMed ID: 18054055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the commonest cystic fibrosis transmembrane regulator gene DeltaF508 mutation: evaluation of PCR--single-strand conformational polymorphism and polyacrylamide gel electrophoresis.
    Kakavas KV; Noulas AV; Kanakis I; Bonanou S; Karamanos NK
    Biomed Chromatogr; 2006 Oct; 20(10):1120-5. PubMed ID: 16708396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A whole-blood homogeneous assay for the multiplex detection of the factor V G1691A and the prothrombin G20210A mutations.
    Hobson-Peters J; Toye P
    Mol Cell Probes; 2005 Aug; 19(4):290-7. PubMed ID: 16006096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
    Alibakhshi R; Zamani M
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of cariogenic bacteria genes by a combination of allele-specific polymerase chain reactions and a novel bioluminescent pyrophosphate assay.
    Arakawa H; Karasawa K; Igarashi T; Suzuki S; Goto N; Maeda M
    Anal Biochem; 2004 Oct; 333(2):296-302. PubMed ID: 15450805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of deltaF508 deletion causing cystic fibrosis, using quantitative real-time PCR].
    Nagy B; Bán Z; Lázár L; Nagy GR; Papp Z
    Orv Hetil; 2006 Jun; 147(24):1119-22. PubMed ID: 16865856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R117H and IVS8-5T cystic fibrosis mutation detection by restriction enzyme digestion.
    Shrimpton AE
    Mol Diagn; 2000 Sep; 5(3):235-8. PubMed ID: 11070158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligation dependent allele specific quantification (LASQ) of CFTR cDNA on the LightCycler using MLPA hybridization probes.
    Schneider M; von Känel T; Sanz J; Gallati S
    Clin Chim Acta; 2009 Apr; 402(1-2):47-53. PubMed ID: 19146842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a semiquantitative PCR assay using internal standard and colorimetric detection on microwell plate for pseudorabies virus.
    Denis M; Soumet C; Legeay O; Arnauld C; Bounaix S; Thiéry R; Jestin A
    Mol Cell Probes; 1997 Dec; 11(6):439-48. PubMed ID: 9500814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.
    Carleton RN; Collimore KC; Asmundson GJ
    J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphatase.
    Heinonen JK; Lahti RJ
    Anal Biochem; 1981 May; 113(2):313-7. PubMed ID: 6116463
    [No Abstract]   [Full Text] [Related]  

  • 37. Colorimetric method for detecting amplified nucleic acids.
    Durward E; Harris WJ
    Biotechniques; 1998 Oct; 25(4):608-12, 614. PubMed ID: 9793641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A colorimetric assay for inorganic pyrophosphate that is also useful for measuring product accumulation in polymerase chain reactions.
    Tagiri-Endo M
    Anal Biochem; 2003 Apr; 315(2):170-4. PubMed ID: 12689826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple colorimetric assay method for pyrophosphate in the presence of a 1000-fold excess of orthophosphate: application of the method to the study of pyrophosphate metabolism in mitochondria.
    Mansurova SE; Deryabina OA
    Anal Biochem; 1989 Feb; 176(2):390-4. PubMed ID: 2545112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorimetric determination of orthophosphate in the assay of inorganic pyrophosphatase activity.
    Horder M
    Anal Biochem; 1972 Sep; 49(1):37-47. PubMed ID: 5081106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.